Kymera Therapeutics

KYMR · NASDAQ

$113.46+$5.39 (+4.99%)TodayMarket closed ·
Prev close $108.07

Who owns KYMR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 72.2% of KYMR’s shares.

  • Fidelity Management & Research Company LLC14.2%
  • Baker Bros. Advisors LP10.5%
  • Avoro Capital Advisors LLC9.1%
  • T. Rowe Price Associates, Inc.8.5%
  • Next 6 largest institutions29.8%
  • All other shareholders27.8%
Top institutional holders of KYMR
HolderShares% of shares
Fidelity Management & Research Company LLC11.72M14.24%
Baker Bros. Advisors LP8.66M10.52%
Avoro Capital Advisors LLC7.47M9.09%
T. Rowe Price Associates, Inc.7.02M8.53%
T. Rowe Price Investment Management, Inc.6.26M7.61%
BlackRock Institutional Trust Company, N.A.4.78M5.81%
BVF Partners L.P.3.87M4.71%
Wellington Management Company, LLP3.68M4.47%
Vanguard Portfolio Management, LLC2.99M3.64%
Invus Public Equities Advisors, LLC2.94M3.57%

Largest mutual fund holders

Top mutual fund holders of KYMR
HolderShares% of shares
T. Rowe Price New Horizons Fund2.26M2.74%
Fidelity Growth Company Fund2.23M2.71%
Vanguard Total Stock Market Index Fund2.10M2.55%
Vanguard Health Care Fund1.80M2.18%
iShares Russell 2000 ETF1.61M1.96%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $343.38M (145 trades) of KYMR on the open market, with no buys.

Latest KYMR insider transactions
InsiderTypeSharesValue
Mainolfi NelloOption exercise30.00K—
Mainolfi NelloSale262$30.42K
Mainolfi NelloSale8.23K$949.74K
Mainolfi NelloSale7.60K$869.78K
Mainolfi NelloSale4.88K$552.16K
Mainolfi NelloSale5.51K$618.98K
Mainolfi NelloSale3.52K$392.83K
Mainolfi NelloOption exercise30.00K$62.40K
Adams BrianSale2.14K$251.25K
Adams BrianSale3.02K$353.35K

Short interest

Settled Sep 30, 2026

Shares short
9.91M
Days to cover
11.97
% of shares outstanding
12.05%
Average daily volume
828.03K
Change since last report
−5.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.